| 1.19 0.06 (5.31%) | 06-23 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.45 | 1-year : | 1.55 |
| Resists | First : | 1.24 | Second : | 1.33 |
| Pivot price | 1.17  |
|||
| Supports | First : | 1.1 | Second : | 0.91 |
| MAs | MA(5) : | 1.15 |
MA(20) : | 1.2 |
| MA(100) : | 1.21 |
MA(250) : | 1.31 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 25.2 |
D(3) : | 22.9 |
| RSI | RSI(14): 50.4 |
|||
| 52-week | High : | 1.91 | Low : | 0.92 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ VANI ] has closed below upper band by 43.4%. Bollinger Bands are 18.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.2 - 1.21 | 1.21 - 1.21 |
| Low: | 1.13 - 1.13 | 1.13 - 1.14 |
| Close: | 1.18 - 1.19 | 1.19 - 1.2 |
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company that specializes in developing innovative implantable medical devices. The firm aims to address chronic diseases for which current treatments are insufficient or lacking. Its key initiatives include a portfolio of miniature drug implants, designed to ensure consistent and stable therapeutic drug delivery, as well as advanced implantable visual prostheses intended to provide meaningful artificial vision to blind individuals. Vivani Medical is headquartered in Emeryville, California.
Mon, 22 Jun 2026
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention - markets.businessinsider.com
Thu, 18 Jun 2026
Vivani Medical Inc (VANI) Institutional Confidence - TradingKey
Fri, 05 Jun 2026
Vivani Medical Highlights Investor Presentation at Jefferies Conference - The Globe and Mail
Fri, 05 Jun 2026
Vivani Medical (VANI) Jefferies Global Healthcare Conference 2026 Summary - Quartr
Wed, 13 May 2026
Vivani Medical, Inc. 1Q 2026: Net income $(6.78M), EPS $(0.08) — 10-Q Summary - TradingView
Fri, 03 Apr 2026
Should I buy Vivani Medical, Inc. (VANI) - Zacks Investment Research
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 86 (M) |
| Shares Float | 37 (M) |
| Held by Insiders | 57.9 (%) |
| Held by Institutions | 6.5 (%) |
| Shares Short | 336 (K) |
| Shares Short P.Month | 351 (K) |
| EPS | -0.41 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.21 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -44.7 % |
| Return on Equity (ttm) | -176.5 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.32 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -25 (M) |
| Levered Free Cash Flow | -16 (M) |
| PE Ratio | -2.98 |
| PEG Ratio | 0 |
| Price to Book value | 5.4 |
| Price to Sales | 0 |
| Price to Cash Flow | -4.05 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|